全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

General Anesthesia for Cesarean Section in a Pregnant Woman with Immune Thrombocytopenic Purpura (ITP): A Case Report and Review of the Literature

DOI: 10.4236/ojanes.2022.121005, PP. 49-54

Keywords: Immune Thrombocytopenia, Pregnancy, Cesarean Section, General Anesthesia, Bleeding

Full-Text   Cite this paper   Add to My Lib

Abstract:

Background: Management of immune thrombocytopenia (ITP) during pre- gnancy can be challenging, particularly by identifying a threshold for safe administration of neuraxial/general anesthesia and minimizing postpartum hemorrhage. There is controversy over the safety of cesarean section (CS) in ITP patients. In this case report, we discuss general anesthesia management in a patient with ITP with severe thrombocytopenia. Case Presentation: A 28-year-old female with relapsed/refractory ITP and severe thrombocytopenia underwent general anesthesia and emergent cesarean section with successful outcomes and minimal bleeding. Platelet counts before CS were 5000 × 109 L, the patient received 1 unit of platelets before the procedure and 1 unit of platelet and tranexamic acid 500 mg was injected slowly during the procedure. No evidence of bleeding and no complications were observed in the patient or newborn. Conclusions: In an emergent circumstance, general anesthesia and cesarean section procedure were performed safely in a patient with severe thrombocytopenia, no hemorrhagic complications were seen for this patient or neonate. Objective of This Manuscript: To share our experience of a safe emergent CS procedure and general anesthesia in a patient with severe thrombocytopenia. Our experience may guide the management of ITP patients in emergent delivery circumstances.

References

[1]  Wang, X., Xu, Y., Luo, W., et al. (2017) Thrombocytopenia in Pregnancy with Different Diagnoses: Differential Clinical Features, Treatments, and Outcomes. Medicine (Baltimore), 96, Article No. e7561.
https://doi.org/10.1097/MD.0000000000007561
[2]  Provan, D., Stasi, R., Newland, A.C., et al. (2010) International Consensus Report on the Investigation and Management of Primary Immune Thrombocytopenia. Blood, 115, 168-186.
https://doi.org/10.1182/blood-2009-06-225565
[3]  Jodkowska, A., Martynowicz, H., Kaczmarek-Wdowiak, B. and Mazur, G. (2015) Thrombocytopenia in Pregnancy—Pathogenesis and Diagnostic Approach. Postępy Higieny i Medycyny Doświadczalnej (Online), 69, 1215-1221.
https://doi.org/10.5604/17322693.1179649
[4]  Reese, J.A., Peck, J.D., Deschamps, D.R., et al. (2018) Platelet Counts during Pregnancy. The New England Journal of Medicine, 379, 32-43.
https://doi.org/10.1056/NEJMoa1802897
[5]  Amorim, J.G., Abecasis, M.R. and Rodrigues, F. (2018) Refractory Severe Thrombocytopenia during Pregnancy: How to Manage. Revista Brasileira de Ginecologia e Obstetrícia, 40, 803-807.
https://doi.org/10.1055/s-0038-1675186
[6]  Rolbin, S.H., Abbott, D., Musclow, E., Papsin, F., Lie, L.M. and Freedman, J. (1988) Epidural Anesthesia in Pregnant Patients with Low Platelet Counts. Obstetrics & Gynecology, 71, 918-920.
[7]  Eslick, R. and McLintock, C. (2020) Managing ITP, and Thrombocytopenia in Pregnancy. Platelets, 31, 300-306.
https://doi.org/10.1080/09537104.2019.1640870
[8]  Rottenstreich, A., Israeli, N., Roth, B., et al. (2020) Risk Factors Associated with Neonatal Thrombocytopenia in Pregnant Women with Immune Thrombocytopenic Purpura. Journal of Maternal-Fetal & Neonatal Medicine, 33, 1572-1578.
https://doi.org/10.1080/14767058.2018.1523891
[9]  Gernsheimer, T., James, A. and Stasi, E. (2013) How I Treat Thrombocytopenia in Pregnancy. Blood, 121, 38-47.
https://doi.org/10.1182/blood-2012-08-448944
[10]  Choi, S. and Brull, R. (2009) Neuraxial Techniques in Obstetric and Non-Obstetric Patients with Common Bleeding Diatheses. Anesthesia & Analgesia, 109, 648-660.
https://doi.org/10.1213/ane.0b013e3181ac13d1

Full-Text

comments powered by Disqus

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133

WeChat 1538708413